Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine, Docetaxel, 5FU and Radiation in Resected Pancreatic and Biliary Cancers
NCT00660699Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Sep 2002
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, docetaxel, fluorouracil in cholangiocarcinoma (CCA), gallbladder cancer, pancreatic cancer (PC), Ampullary cancer (AC), sponsored by Washington University School of Medicine. Started Sep 2002; status: completed.
02
Drugs
gemcitabinedocetaxelfluorouracil
03
Conditions
cholangiocarcinoma (CCA)gallbladder cancerpancreatic cancer (PC)Ampullary cancer (AC)
Beyond the preview
Go deeper on NCT00660699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00660699.